195 related articles for article (PubMed ID: 31173299)
1. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
[TBL] [Abstract][Full Text] [Related]
2. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
Sun YW; Li XH; Wang H; Wu J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
Yuan Q; Sun T; Ye F; Kong W; Jin H
Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
[TBL] [Abstract][Full Text] [Related]
4. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
Chang X; Zhang H; Lian S; Zhu W
Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Wu J; Li J; Ren J; Zhang D
Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
7. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
8. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
9. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
11. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
[TBL] [Abstract][Full Text] [Related]
13. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136.
Huang YL; Xu Q; Wang X
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2888-2897. PubMed ID: 31002140
[TBL] [Abstract][Full Text] [Related]
15. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
17. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
18. Down-regulated expression of miR-582 predicts poor prognosis and facilitates melanoma progression by targeting FOXC1.
Chen F; Zhang D
Arch Dermatol Res; 2022 Oct; 314(8):759-766. PubMed ID: 34628519
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]